Mikkel Z Oestergaard
Mikkel Z Oestergaard
Merck / MSD
Bekræftet mail på merck.com
Citeret af
Citeret af
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
H Blencowe, S Cousens, MZ Oestergaard, D Chou, AB Moller, R Narwal, ...
The Lancet 379 (9832), 2162-2172, 2012
Born too soon: the global epidemiology of 15 million preterm births
H Blencowe, S Cousens, D Chou, M Oestergaard, L Say, AB Moller, ...
Reproductive health 10 (1), 1-14, 2013
Neonatal mortality levels for 193 countries in 2009 with trends since 1990: a systematic analysis of progress, projections, and priorities
MZ Oestergaard, M Inoue, S Yoshida, WR Mahanani, FM Gore, ...
PLoS Med 8 (8), e1001080, 2011
Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology, 2017
Cancer genetics of epigenetic genes
A Miremadi, MZ Oestergaard, PDP Pharoah, C Caldas
Human molecular genetics 16 (R1), R28-R49, 2007
Newborn survival: a multi-country analysis of a decade of change
JE Lawn, MV Kinney, RE Black, C Pitt, S Cousens, K Kerber, E Corbett, ...
Health policy and planning 27 (suppl_3), iii6-iii28, 2012
Child mortality estimation: accelerated progress in reducing global child mortality, 1990–2010
K Hill, D You, M Inoue, MZ Oestergaard
PLoS Med 9 (8), e1001303, 2012
A new method for deriving global estimates of maternal mortality
JR Wilmoth, N Mizoguchi, MZ Oestergaard, L Say, CD Mathers, ...
Statistics, Politics, and Policy 3 (2), 2012
The role of a bioresource research impact factor as an incentive to share human bioresources
A Cambon-Thomsen, GA Thorisson, L Mabile
Nature genetics 43 (6), 503, 2011
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
M Klanova, LH Sehn, I Bence-Bruckler, F Cavallo, J Jin, M Martelli, ...
blood 133 (9), 919-926, 2019
Common variants in mismatch repair genes and risk of colorectal cancer
T Koessler, MZ Oestergaard, H Song, J Tyrer, B Perkins, AM Dunning, ...
Gut 57 (8), 1097-1101, 2008
South African child deaths 1990–2011: have HIV services reversed the trend enough to meet Millennium Development Goal 4?
KJ Kerber, JE Lawn, LF Johnson, M Mahy, RE Dorrington, H Phillips, ...
AIDS (London, England) 27 (16), 2637, 2013
PD-L1 and tumor-associated macrophages in de novo DLBCL
R McCord, CR Bolen, H Koeppen, EE Kadel, MZ Oestergaard, T Nielsen, ...
Blood advances 3 (4), 531-540, 2019
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA …
C Kurzeder, I Bover, F Marmé, J Rau, P Pautier, N Colombo, D Lorusso, ...
Journal of Clinical Oncology 34 (21), 2516-2525, 2016
Evaluation of the m7-FLIPI in Patients with Follicular Lymphoma Treated within the Gallium Trial: EZH2 mutation Status May be a Predictive Marker for Differential …
V Jurinovic, V Passerini, MZ Oestergaard, A Knapp, K Mundt, S Araf, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
Interactions between genes involved in the antioxidant defence system and breast cancer risk
MZ Oestergaard, J Tyrer, A Cebrian, M Shah, AM Dunning, BAJ Ponder, ...
British journal of cancer 95 (4), 525-531, 2006
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
Clinical Cancer Research 25 (15), 4634-4643, 2019
Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study
CR Bolen, M Klanova, M Trneny, LH Sehn, J He, J Tong, JN Paulson, ...
haematologica 105 (9), 2020
Prognostic impact of BCL2 and MYC expression and translocation in untreated DLBCL: results from the phase III GOYA study
LH Sehn, MZ Oestergaard, M Trněný, A Bosi, M Egyed, A Illes, ...
Hematological Oncology 35, 131-133, 2017
An idea whose time has come ?An African foresight observatory on genomics medicine and data-intensive global science
C Dandara, C Adebamowo, J de Vries, E S Dove, E Fisher, R A Gibbs, ...
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2012
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20